News and reflections from the world of AI

    February 22, 2021

    AI in toxicologic pathology publications’ summaries

    AI-based bone marrow screening Screening For Bone Marrow Cellularity Changes in Cynomolgus Macaques in Toxicology Safety Studies Using Artificial Intelligence Models Mark A. Smith, Thomas Westerling-Bui, Angela Wilcox, Julie Schwartz
    Written by Aiforia
    February 4, 2021

    DECIDER project launches to improve diagnostics and treatment of ovarian cancer

    The European Union has funded a project to improve personalized treatments for ovarian cancer with nearly 15 million euros for five years. The international DECIDER project has partners from 14 organizations in seven EU countries.
    Written by Aiforia
    January 19, 2021

    Aiforia feature: Multi-channel Images and Analysis

    Unlimited channels, limitless data  Aiforia’s multi-channel viewing and analysis capabilities can be applied to any image allowing for hundreds of channels to be imported and processed.
    Written by Aiforia
    January 11, 2021

    Interview with Veterinary Pathologist, Professor Garry Adams, on developing AI models with Aiforia Create

    Professor Garry Adams, DVM, PhD, Diplomate, American College of Veterinary Pathologists, is a Senior Professor at the Department of Veterinary Pathobiology, Texas A&M University. He is also an Aiforia Create user, developing AI models to review tissues.
    Written by Aiforia
    January 11, 2021

    The impact of digital pathology on immuno-oncology

    Immuno-oncology (IO) relies on harnessing our own immune systems in order to develop personalized therapies and medications for cancer. For this, a deep understanding of the immune system as well as its role in the regulation of the tumor microenvironment (TME) is pivotal. 
    Written by Aiforia
    January 7, 2021

    Leiden University Medical Center case study: AI-driven PD-L1 scoring in lung cancer

    Describe your project with Aiforia. Liesbeth: We created an AI model, a deep learning algorithm, for PD-L1 scoring in NSCLC histology earlier and are now aiming to validate this AI model in other laboratory workups as well, including different antibodies and scanners. We will describe the steps that are needed for adapting an existing AI model to a new, local laboratory workup (domain ...
    Written by Aiforia
    6 7 8 9 10